/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Efficacy of intravenous iron therapy compared to usual treatment in iron deficient adult cyanotic congenital heart disease patients for improvement in clinical outcomes at three months
Event: ESC Congress 2023
Topic: Adult Congenital Heart Disease (ACHD)
Session: Pharmacotherapy and biomarkers in adult congenital heart disease: do the same rules apply?
